Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Br J Haematol. 2017 Sep 7;179(4):648–656. doi: 10.1111/bjh.14918

Figure 1. Study Enrolment Diagram.

Figure 1

A total of 57 subjects signed consent and completed study procedures. Two had no interpretable contrast data for technical reasons. Six controls were excluded for a BMI > 40 kg/m2. One SCD patient was excluded for a glucose level of > 22.2 mmol/l. There were 48 evaluable patients in the study (27 controls, 21 SCD patients of whom 15 were on HC). BMI: body mass index; HC: hydroxycarbamide; SCD: sickle cell disease.